Header

Header

irinotecan

Pharma / Biotech

September 25, 2022
166

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation
Gastroenterology

September 3, 2022
155

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
Pharma / Biotech

August 19, 2022
142

DailyMed – IRINOTECAN HYDROCHLORIDE injection
Pharma / Biotech

April 18, 2022
169

Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammation
Pharma / Biotech

April 18, 2022
166

Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammation
Gastroenterology

December 26, 2018
134

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype
Surgery/Cosmetic

November 12, 2018
143

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial.